• Amprius Technologies, Inc. has completed its at-the-market and follow-on equity offerings, issuing an aggregate 25.5 million common shares and raising about US$97.5 million in net proceeds, effectively ending the program.
• This fundraising significantly bolsters Amprius’ capital base, potentially giving it more flexibility to fund manufacturing expansion, automation projects, and long-cycle customer programs.
• We’ll now examine how completing this US$97.5 million equity raise could influence Amprius Technologies’ existing investment narrative and risk profile.

Find companies with promising cash flow potential yet trading below their fair value.

Amprius Technologies Investment Narrative Recap

To own Amprius Technologies, you need to believe its silicon anode batteries can convert early traction in aviation and drones into a scalable, profitable business. The US$97.5 million equity raise improves near term funding for expansion, but it does not remove the core execution risk around scaling production or the revenue concentration in a few end markets, which still looks like the key swing factor for the stock.

The recently expanded Amprius Korea Battery Alliance, which now includes three additional contract manufacturers and over 2 GWh of global capacity, ties directly into how this new capital might be used: funding automation, ramping output, and supporting larger customer programs. Together, the alliance and the fresh equity underline how much of the Amprius story now hinges on turning contracted capacity into efficient, reliable, and margin-supportive production.

Yet behind this stronger balance sheet, investors should be aware of how equity-funded expansion can still leave them exposed to...

Amprius Technologies' narrative projects $306.6 million revenue and $13.4 million earnings by 2028. This requires 89.8% yearly revenue growth and a $52.1 million earnings increase from $-38.7 million today.

Uncover how Amprius Technologies' forecasts yield a $17.17 fair value, a 81% upside to its current price.

Exploring Other Perspectives

Twelve fair value estimates from the Simply Wall St Community span roughly US$10.94 to US$47.14 per share, highlighting very different expectations for Amprius. Against that backdrop, the increased reliance on equity funding and potential dilution makes it even more important to understand how your own view of execution risk and capital needs compares to other investors before committing capital.

Explore 12 other fair value estimates on Amprius Technologies - why the stock might be worth just $10.94!

Build Your Own Amprius Technologies Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Amprius Technologies research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Amprius Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amprius Technologies' overall financial health at a glance.

Curious About Other Options?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• These 19 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• We've found 12 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.